INTRODUCTION
Pilomatrixoma, also known as pilomatricoma or calcifying epithelioma of Malherbe, was first described by Malherbe and Chenantais in 1880 [
1]. In 1961, Forbis and Helwig [
2] proposed the term “pilomatrixoma” instead of “calcifying epithelioma,” because studies showed definite similarities in both tumor and hair, thus elucidating the hair follicle matrix as the point of origin. Pilomatrixoma is a rare benign tumor with an incidence of approximately 1% among benign skin lesions [
3].
Previous studies revealed pilomatrixoma presentation in young patients aged less than 20 years with a female predominance. The head, neck, and extremities are the main regions in which the tumor occurred. Pilomatrixoma typically presents as a solitary lesion, although some patients still present multiple lesions [
4].
Clinically, pilomatrixoma commonly presents as a hard, freely mobile, and slow-growing mass. Patients are usually asymptomatic, but in some cases, patients complain of pain or discharge from the lesions [
5,
6]. Pilomatrixoma is located in the deep dermis or in the subcutaneous layer, presenting as a subcutaneous mass. Occasionally, clearly demarcated vessels or skin ulcerations can even be seen as the overlying skin attenuates [
6,
7]. The varied clinical appearance of pilomatrixoma is associated with a diagnostic flaw, wherein it is easily misdiagnosed as other skin masses, such as epidermal cyst or dermoid cyst, resulting in a low percentage of correct preoperative diagnosis 16% [
7,
8]. In our opinion, it is necessary to classify the types of pilomatrixoma because of its varied presentations, thereby enabling easier diagnosis. Therefore, we investigated the clinical data of pediatric patients with pilomatrixoma, especially focusing on the clinical features and imaging findings. There have been few records of case reports on pilomatrixoma and a single study of pilomatrixoma in adults [
9] to date; thus, this is the first large-scale clinical study of pilomatrixoma in pediatric patients from Korea.
DISCUSSION
Pilomatrixoma, arising from the hair follicle matrix, is generally a benign tumor occurring in the deep dermis or subcutaneous layer. It usually presents as a solitary lesion, although it presents as multiple lesions in approximately 2% to 9% of cases [
8]. In our study, 7.88% of cases presented with MP. The cause of pilomatrixoma remains unclear, previous studies have suggested that the development of pilomatrixoma is related to β-catenin mutation [
10]. In addition, MP is reported to be associated with familial inheritance or general syndromic conditions, such as myotonic dystrophy, Gardner syndrome, and Turner’s syndrome [
11].
Epidemiologically, pilomatrixoma can occur at any age. Previous studies showed that there are two age peaks in which pilomatrixoma occurs intensively: first peak is in young patients aged between 0 and 20 years, whereas the second is in older patients aged between 40 and 60 years [
12]. A retrospective study of 2,189 cases demonstrated that more than half of pilomatrixomas occurred in pediatric patients aged <20 years [
8]. Moreover, among pediatric patients, the majority of cases occurred before 10 years of age [
8,
13]. In this study, 149 cases (93.3%) occurred before 10 years of age which is consistent with that reported in previous studies. The four cases of pilomatrixoma collected in adults during the same period were excluded from this study.
Based on previous retrospective studies, both SP and MP presentation had a female predominance [
8,
13]. In addition, the most common area of pilomatrixoma occurrence was in the head and neck, mainly in the cheek or the palpebral area, followed by the upper extremities, trunk, and lower extremities [
4]. Similarly, in this study, female predominance (63.03%) was also observed with a common occurrence in the head and neck region.
Moreover, the clinical manifestations of pilomatrixomas are diverse. Generally, pilomatrixoma is a hard, freely mobile, slow-growing mass covered by skin. Patients are asymptomatic, although in some cases pilomatrixoma may present with symptoms, such as pain, pruritus or discharge in lesions [
5-
7], which makes the diagnosis more difficult. In our study, five clinical types of pilomatrixoma presentation were established according to the characteristic appearance of the lesions. The mass type was the most common (56.02%), with a firm calcified nodule protruding from the skin. In some cases, the tumor showed multiple facets and angles referred to as “tent sign” [
14], which is a helpful feature for the diagnosis of pilomatrixoma. The pigmentation type was the second most common presentation of pilomatrixoma (25.31%). Bowers and Millard [
15] showed that pilomatrixoma could be covered by small vessels that made the skin red or blue in color. In addition, Ishida and Okabe [
16] showed that melanin pigment and melanocytes existed in the pilomatrixoma, identified as pigmented pilomatrixoma. There were 21 lesions (12.65%) that presented as protuberant nodules with discoloration of the skin, and these were classified as the mixed type. Moreover, once a pilomatrixoma forms in the superficial papillary or mid-dermis, the tumor may perforate from the skin through a process of transdermal elimination, leading to ulceration [
4,
17]. This characteristic is rare with only 4.28% cases presenting with perforating pilomatrixomas, and these were classified as the ulceration type. There was a special type defined as the keloid-like type in two lesions. Compared with the mass type, the keloid-like type lesions were characterized by excessive growth beyond the original area of the lesion; thus, it was easily misdiagnosed as a keloid or hypertrophic scar. The varieties of pilomatrixoma clinical features contribute to the increased tendency for misdiagnosis for other skin lesions. Differential diagnosis of epidermoid or dermoid cyst, calcified hematoma, and foreign body reaction are necessary considerations.
In order to improve the diagnostic rate of pilomatrixoma, preoperative imaging including US, CT, or MRI is recommended. Compared with CT and MRI, US is considered a non-anesthetic, noninvasive, low-priced, quick, and acceptable approach for children with high accuracy of more than 80% [
18]. In this study, US had a positive predictive value of 95.56%. Generally, on US, the pilomatrixoma is described as an oval, well-defined, heterogeneous, hyperechoic subcutaneous mass with or without posterior shadowing [
18,
19] (
Fig. 5).
Complete surgical resection is the treatment of choice for pilomatrixomas. The tumor occurs predominantly in the head and neck region; thus, indirect incisions are often used for cosmetic reasons. Take, for example, a hairline incision adapted to approach the mass in the forehead or the temple for cosmesis. These surgical procedures should be carefully approached to avoid injury to the facial nerve or sensory nerve branches of the face. After tumor removal in the giant pilomatrixoma, the defective skin should be reconstructed with a flap [
20,
21].
Although recurrent pilomatrixoma is rare, approximately 2% of cases still recur [
8]. Some case reports showed that the postoperative recurrence time ranged from 1 year to decades [
22,
23]. In our study, the average recurrence time in two cases (1.2%) was 15.5 months, postoperatively. The cause of recurrence is generally due to incomplete resection, especially when the tumor occurs in a sensitive location; thus, sufficient resection margins are recommended to reduce the recurrence rate [
23].
Malignant transformation of the pilomatrixoma is very rare. Previous case reports and case series indicated that malignant transformation occurred only in adult patients [
24,
25]. However, Otero et al. [
26] has reported the first pediatric case of a malignant pilomatrixoma transformation from a previous operation site; thus targeted clinical evaluation should be performed to rule out the risk of malignant changes in recurrent pilomatrixomas.
In conclusion, pilomatrixoma commonly presents as a solitary mass lesion on the face. Although the clinical appearances of pilomatrixoma vary, making misdiagnosis common, the established clinical classifications of pilomatrixoma presentations may help in the identification when compared with other skin tumors. US is also a helpful imaging tool for the diagnosis of pilomatrixoma. Complete surgical excision is the treatment of choice with a low recurrence rate.